Additional Her 2/neu gene copies in patients with Sézary syndrome

Leukemia Research

Volumn 30, Issue 6, 2006, Pages 755-760

  Utikal, Jochen ^a   Poenitz, Nina ^a   Gratchev, Alexei ^a   Klemke, Claus Detlev ^a   Nashan, Dorothea ^b   Tüting, Thomas ^c   Goerdt, Sergij ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Chromosome 17; CTCL; FISH; Her 2 neu; S zary Syndrome

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CENTROMERE; CHROMOSOME 17; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MORBIDITY; ONCOGENE NEU; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; CENTROMERE; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 33645298759     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.10.012     Document Type: Article

References (17)

1. E. Dippel, C. Assaf, and M. Hummel Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation J Pathol 188 1999 146 154
2. E. Dippel, D. Klemke, and M. Hummel T-cell clonality of undetermined significance Blood 98 2001 247 248
3. L. Karenko, E. Hyytinen, and S. Sarna Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods J Invest Dermatol 108 1997 22 29
4. M. Thangavelu, W.G. Finn, and K.K. Yelavarthi Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome Blood 89 1997 3371 3377
5. J.J. Scarisbrick, A.J. Woolford, and R. Russell-Jones Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p J Invest Dermatol 117 2001 663 670
6. X. Mao, D.M. Lillington, and B. Czepulkowski Molecular cytogenetic characterization of Sézary syndrome Genes Chromosomes Cancer 36 2003 250 260
7. T.C. Fischer, S. Gellrich, and J.M. Muche Genomic aberrations and survival in cutaneous T cell lymphomas J Invest Dermatol 122 2004 579 586
8. S. Kaptain, L.K. Tan, and B. Chen Her-2/neu and breast cancer Diagn Mol Pathol 10 2001 139 152
9. Nathanson DR, Culliford 4th AT, Shia J, et al. HER 2/neu expression and gene amplification in colon cancer. Int J Cancer 2003;105:796-802.
10. J.L. Inman, T. Kute, and W. White Absence of HER2 overexpression in metastatic malignant melanoma J Surg Oncol 84 2003 82 88
11. M. Udart, J. Utikal, and G.M. Krahn Chromosome 7 aneusomy, A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases Neoplasia 3 2001 245 254
12. J. Utikal, M. Udart, U. Leiter, R.U. Peter, and G. Krahn Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma Int J Oncol 26 2005 597 605
13. A.H. Hopman, C.E. Voorter, and F.C. Ramaekers Detection of genomic changes in cancer by in situ hybridization Mol Biol Rep 19 1994 31 44
14. V.H. Sommer, O.J. Clemmensen, and O. Nielsen In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3 Leukemia 18 2004 1288 1295
15. C. Brender, P. Lovato, and V.H. Sommer Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha Leukemia 19 2005 209 213
16. C.L. Vogel, M.A. Cobleigh, and D. Tripathy Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J Clin Oncol 20 2002 719 726
17. G. Pauletti, S. Dandekar, and H. Rong Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry J Clin Oncol 18 2000 3651 3664